Worth Venture Partners, LLC Abeona Therapeutics Inc. Transaction History

Worth Venture Partners, LLC

  • $12 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
SELL
$3.71 - $5.14 $314,760 - $436,082
-84,841 Reduced 30.16%
196,439 $984,000
Q3 2023

Nov 14, 2023
BUY
$2.98 - $4.43 $363,467 - $540,322
121,969 Added 76.56%
281,280 $1.18 Million
Q2 2023

Aug 14, 2023
SELL
$2.76 - $5.27 $3,311 - $6,323
-1,200 Reduced 0.75%
159,311 $642,000
Q4 2022

Feb 14, 2023
BUY
$2.4 - $5.65 $301,771 - $710,419
125,738 Added 361.6%
160,511 $494,000
Q2 2022

Aug 15, 2022
BUY
$3.5 - $8.5 $121,705 - $295,570
34,773 New
34,773 $169,000

Others Institutions Holding ABEO

# of Institutions
57
Shares Held
28.4M
Call Options Held
827K
Put Options Held
44.5K
View Full List

About ABEONA THERAPEUTICS INC.

ABEO Quotes by TradingView
  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $35M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Worth Venture Partners, LLC Portfolio

Follow Worth Venture Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email